SELECTION OF GAMMA-RAY EMITTING ISOTOPES AS PERMANENT IMPLANTS IN THE TREATMENT OF CANCER
Journal Article
·
· Phys. in Med. Biol.
It is shown that the optimal biological dosage factors for permanent implants of gamma-ray emitting radioactive sources can be estimated by using empirical formulae relating the observed reactions of irradiated squamous cancer and normal human skin to the physical dosage, the relative biological efficiency of the radiation used, the size of the treated field, and the timeparameter appropriate to the exponentially decaying source. On this basis the optimal initial dose-rates (r/hr) or, in the case of discrete grains, the optimal initial millicurie content per grain, for interstitial application of Au/sup 198/, Rn/sup 222/, Bi/sup 206/, I/sup 131/, Ba/sup 140/-La Cr/sup 51/, Ir/sup 192/, and Ta/sup 182/ are tabulated. The longer-lived materials are shown to have certain advantages, and it is suggested that moderately long-lived sources with half- lives of the order of 20 days are likely to prove clinically superior to conventionally used materials. (auth)
- Research Organization:
- General Hospital, Johannesburg, South Africa
- NSA Number:
- NSA-12-009649
- OSTI ID:
- 4327832
- Journal Information:
- Phys. in Med. Biol., Journal Name: Phys. in Med. Biol. Vol. Vol: 2
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Similar Records
AN ISOTOPE HANDLING CALCULATOR (MK.2)
Permanent and removable implants for the brachytherapy of brain tumors
Radioactive iodine-125 implantation for cancer of the prostate
Technical Report
·
Sun Jun 01 00:00:00 EDT 1958
·
OSTI ID:4310639
Permanent and removable implants for the brachytherapy of brain tumors
Journal Article
·
Thu Oct 01 00:00:00 EDT 1981
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:5763426
Radioactive iodine-125 implantation for cancer of the prostate
Journal Article
·
Mon Dec 31 23:00:00 EST 1984
· Prostate (N.Y.); (United States)
·
OSTI ID:5148661